COPD

COPD is a chronic lung disease. To date, no cure exists for COPD and therefore most treatments focus on reducing symptoms and suppressing discomfort.

Multiple Sclerosis

Multiple Sclerosis is one of the diseases where a therapeutic role for cannabinoids has been investigated for a long time.

Obesity

Energy homeostasis (balance)  is one of the primary functions of the endocannabinoid system.

OCD

OCD is an anxiety disorder characterised by the obsessive urge for repetitive behaviour.

Psoriasis

Psoriasis is an auto-immune disease characterized by itchy skin lesions. Psoriasis arises when the immune system mistakenly identifies skin cells as foreign matter and causes over-production of new skin cells.

Stroke

A stroke is marked by reduced blood flow to the brain. This reduction can be due to a blocked blood vessle (ischaemia) or a ruptured blood vessle (aneurism). Either way, as a result (part of) the brain is deprived of oxygen and nutrients which in turn causes neuronal degradation and cognitive decline.

Tinnitus

Tinnitus is described as a sensation of hearing sounds without any external source. This sensation can be similar to hear ringing, clicking, hissing or other sounds.

Alzheimer's disease

Alzheimer’s disease is a chronic neurodegenerative disease and the main cause of dementia. Main common symptoms of dementia are related with memory but other cognitive processes are affected during the development of the disease.

Parkinson's

Parkinson's Disease is a degenerative disorder of the nervous system marked by accelerated degeneration of dopamine-producing neurons in the Substantia Nigra in the brain.

Typical symptoms of Parkinson's Disease , such as (intentional) tremor, rigidity and slowness of movement are mostly ascribed to degenerating Substantia Nigra neurons.

Cancer

In spite of the increasing scientific interest to understand how cannabinoids can help to treat cancer disease, symptoms and the associated chemotherapy side effects, the existing scientific evidence is not enough to satisfy the clinical criteria to consider cannabinoids as a part of the treatment.